Filing Details
- Accession Number:
- 0001209191-22-014267
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-01 18:03:34
- Reporting Period:
- 2022-02-28
- Accepted Time:
- 2022-03-01 18:03:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184778 | W Gary Pace | C/O Pacira Biosciences, Inc. 5401 West Kennedy Boulevard, Suite 890 Tampa FL 33609 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-28 | 9,807 | $11.02 | 139,337 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-02-28 | 18,834 | $11.02 | 158,171 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-28 | 28,641 | $66.83 | 129,530 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 193 | $11.02 | 129,723 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 1,166 | $11.02 | 130,889 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-01 | 1,359 | $67.75 | 129,530 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-28 | 9,807 | $0.00 | 9,807 | $11.02 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-02-28 | 18,834 | $0.00 | 18,834 | $11.02 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-03-01 | 193 | $0.00 | 193 | $11.02 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-03-01 | 1,166 | $0.00 | 1,166 | $11.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 193 | 2022-04-02 | No | 4 | M | Direct | |
| 1,166 | 2022-04-02 | No | 4 | M | Direct | |
| 0 | 2022-04-02 | No | 4 | M | Direct | |
| 0 | 2022-04-02 | No | 4 | M | Direct |
Footnotes
- he price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.750 to $67.155, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on May 3, 2012.
- The option vested and became exercisable as to 25% of the option shares on April 3, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.
Billionaire Hedge Funds
